Insider · CIK 0001886431
Fitzgerald Kevin Joseph
officerdirector
Files at ALNY (ALNYLAM PHARMACEUTICALS, INC.), OVID (Ovid Therapeutics Inc.). First filing Nov 27, 2024, latest Mar 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $2.1M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 35Weak | sell 510b5-1 | ALNY ALNYLAM PHARMACEUTICALS, INC. | $669k | 2,755 | -17% | +5% from low · -19% from high | |
| 40Moderate | sell 5 | ALNY ALNYLAM PHARMACEUTICALS, INC. | $120k | 496 | -4% | +6% from low · -18% from high | |
| 33Weak | sell 510b5-1 | ALNY ALNYLAM PHARMACEUTICALS, INC. | $531k | 2,103 | -14% | +10% from low · -15% from high | |
| 37Weak | sell 510b5-1 | ALNY ALNYLAM PHARMACEUTICALS, INC. | $755k | 3,000 | -19% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Common Stock10b5-1 | +3,871 | $0.00 | $0 | 16,256 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -204 | $242.37 | $49k | 16,052 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -224 | $243.36 | $55k | 15,828 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -151 | $244.41 | $37k | 15,677 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -111 | $245.26 | $27k | 15,566 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -45 | $246.18 | $11k | 15,521 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4 | $247.35 | $989 | 15,517 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1 | $248.36 | $248 | 15,516 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -465 | $242.69 | $113k | 15,051 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -487 | $243.94 | $119k | 14,564 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -219 | $245.30 | $54k | 14,345 | Mar 5, 2025 |
| Mar 4, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -121 | $239.24 | $29k | 14,224 | Mar 5, 2025 |
| Mar 4, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -328 | $240.95 | $79k | 13,896 | Mar 5, 2025 |
| Mar 4, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -324 | $241.68 | $78k | 13,572 | Mar 5, 2025 |
| Mar 4, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -71 | $242.93 | $17k | 13,501 | Mar 5, 2025 |
| Mar 3, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Stock Option (right to buy)derivative10b5-1 | +7,819 | $0.00 | $0 | 7,819 | Mar 5, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -27 | $236.51 | $6,386 | 12,854 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -21 | $238.33 | $5,005 | 12,833 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -22 | $239.18 | $5,262 | 12,811 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -48 | $240.32 | $12k | 12,763 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -79 | $241.51 | $19k | 12,684 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -187 | $242.44 | $45k | 12,497 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -75 | $243.23 | $18k | 12,422 | Mar 3, 2025 |
| Feb 28, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -37 | $244.11 | $9,032 | 12,385 | Mar 3, 2025 |
| Feb 13, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Common Stock10b5-1 | +2,103 | $0.00 | $0 | 14,984 | Feb 18, 2025 |
| Feb 14, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -145 | $252.50 | $37k | 14,839 | Feb 18, 2025 |
| Feb 14, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -164 | $253.37 | $42k | 14,675 | Feb 18, 2025 |
| Feb 14, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -110 | $254.35 | $28k | 14,565 | Feb 18, 2025 |
| Feb 14, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -47 | $255.56 | $12k | 14,518 | Feb 18, 2025 |
| Feb 14, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -53 | $256.29 | $14k | 14,465 | Feb 18, 2025 |
| Feb 14, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -26 | $257.51 | $6,695 | 14,439 | Feb 18, 2025 |
| Feb 14, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -33 | $258.07 | $8,516 | 14,406 | Feb 18, 2025 |
| Feb 14, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -12 | $259.72 | $3,117 | 14,394 | Feb 18, 2025 |
| Feb 14, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -21 | $260.57 | $5,472 | 14,373 | Feb 18, 2025 |
| Feb 14, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -26 | $261.45 | $6,798 | 14,347 | Feb 18, 2025 |
| Feb 14, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -12 | $263.33 | $3,160 | 14,335 | Feb 18, 2025 |
| Feb 14, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -14 | $264.87 | $3,708 | 14,321 | Feb 18, 2025 |
| Feb 18, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,086 | $250.21 | $272k | 13,235 | Feb 18, 2025 |
| Feb 18, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -115 | $251.60 | $29k | 13,120 | Feb 18, 2025 |
| Feb 18, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -80 | $256.05 | $20k | 13,040 | Feb 18, 2025 |
| Feb 18, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -76 | $257.79 | $20k | 12,964 | Feb 18, 2025 |
| Feb 18, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -83 | $259.10 | $22k | 12,881 | Feb 18, 2025 |
| Dec 12, 2024 | OVID Ovid Therapeutics Inc. | AGrant or award Stock Option (Right to Buy)derivative | +90,000 | $0.00 | $0 | 90,000 | Dec 16, 2024 |
| Nov 25, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Common Stock10b5-1 | +3,000 | $0.00 | $0 | 15,881 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -26 | $247.77 | $6,442 | 15,855 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -215 | $249.60 | $54k | 15,640 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -318 | $250.68 | $80k | 15,322 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -826 | $251.42 | $208k | 14,496 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -84 | $252.27 | $21k | 14,412 | Nov 27, 2024 |
| Nov 27, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -210 | $250.45 | $53k | 14,202 | Nov 27, 2024 |
| Nov 27, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -851 | $251.98 | $214k | 13,351 | Nov 27, 2024 |
| Nov 27, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -360 | $253.44 | $91k | 12,991 | Nov 27, 2024 |
| Nov 27, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -110 | $254.48 | $28k | 12,881 | Nov 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.